Unicycive Therapeutics, Inc.(UNCY)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

UNCY Unicycive Therapeutics, Inc.

盘前交易 12-23 07:45:13 EST

0.6840

-0.0260

-3.66%

盘前0.6900

+0.0060+0.88%

07:15 EST

最高0.7440	最低0.6800	成交量133.82万
今开0.7200	昨收0.7100	日振幅9.01%
总市值7,100万	流通市值4,203万	总股本1.04亿
成交额94.94万	换手率2.18%	流通股本6,145万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"UNCY","market":"US","secType":"STK","nameCN":"Unicycive Therapeutics, Inc.","latestPrice":0.684,"timestamp":1734728400000,"preClose":0.71,"halted":0,"volume":1338162,"hourTrading":{"tag":"盘前","latestPrice":0.69,"preClose":0.684,"latestTime":"07:15 EST","volume":917,"amount":633.0891889000001,"timestamp":1734956139906},"delay":0,"floatShares":61454000,"shares":103796406,"eps":-0.489086,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.026,"latestTime":"12-23 07:45:13 EST","open":0.72,"high":0.744,"low":0.68,"amount":949372.760442,"amplitude":0.090141,"askPrice":0.73,"askSize":188,"bidPrice":0.685,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-0.489086,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734964200000},"adr":0,"listingDate":1623988800000,"adjPreClose":0.684,"preHourTrading":{"tag":"盘前","latestPrice":0.69,"preClose":0.684,"latestTime":"07:15 EST","volume":917,"amount":633.0891889000001,"timestamp":1734956139906},"postHourTrading":{"tag":"盘后","latestPrice":0.6999,"preClose":0.684,"latestTime":"19:55 EST","volume":45157,"amount":31061.166554,"timestamp":1734742534529},"volumeRatio":1.16666056389178},"requestUrl":"/m/hq/s/UNCY","defaultTab":"news","newsList":[{"id":"2491371490","title":"Unicycive Therapeutics, Inc.盘中异动 早盘快速下跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491371490","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491371490?lang=zh_cn&edition=full","pubTime":"2024-12-13 22:52","pubTimestamp":1734101544,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日22时52分，Unicycive Therapeutics, Inc.股票出现异动，股价快速跳水5.41%。Unicycive Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。Unicycive Therapeutics, Inc.公司简介：Unicycive Therapeutics Inc是一家生物技术公司，致力于开发针对某些疾病的治疗方法。Unicycive 的另一款药物 UNI-494 是一种新的化学实体，在晚期临床前开发中已获得物质成分专利保护，用于治疗急性肾损伤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213225224a1ec3c87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213225224a1ec3c87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4539","UNCY"],"gpt_icon":0},{"id":"2488281829","title":"Unicycive Therapeutics, Inc.盘中异动 快速跳水5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488281829","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488281829?lang=zh_cn&edition=full","pubTime":"2024-12-04 00:44","pubTimestamp":1733244264,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日00时44分，Unicycive Therapeutics, Inc.股票出现波动，股价快速跳水5.22%。Unicycive Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。Unicycive Therapeutics, Inc.公司简介：Unicycive Therapeutics Inc是一家生物技术公司，致力于开发针对某些疾病的治疗方法。Unicycive 的另一款药物 UNI-494 是一种新的化学实体，在晚期临床前开发中已获得物质成分专利保护，用于治疗急性肾损伤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204004424abf33817&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204004424abf33817&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","LENZ","UNCY"],"gpt_icon":0},{"id":"2487556838","title":"Unicycive Therapeutics, Inc.盘中异动 快速上涨5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2487556838","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487556838?lang=zh_cn&edition=full","pubTime":"2024-11-29 22:43","pubTimestamp":1732891428,"startTime":"0","endTime":"0","summary":"北京时间2024年11月29日22时43分，Unicycive Therapeutics, Inc.股票出现波动，股价大幅上涨5.96%。Unicycive Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。Unicycive Therapeutics, Inc.公司简介：Unicycive Therapeutics Inc是一家生物技术公司，致力于开发针对某些疾病的治疗方法。Unicycive 的另一款药物 UNI-494 是一种新的化学实体，在晚期临床前开发中已获得物质成分专利保护，用于治疗急性肾损伤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129224348971aa72c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129224348971aa72c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["UNCY","BK4139","LENZ","BK4539"],"gpt_icon":0},{"id":"2486466838","title":"Unicycive Therapeutics, Inc.盘中异动 下午盘大幅上涨5.41%报0.583美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486466838","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486466838?lang=zh_cn&edition=full","pubTime":"2024-11-27 03:26","pubTimestamp":1732649199,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日03时26分，Unicycive Therapeutics, Inc.股票出现异动，股价快速上涨5.41%。Unicycive Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Unicycive Therapeutics, Inc.公司简介：Unicycive Therapeutics Inc是一家生物技术公司，致力于开发针对某些疾病的治疗方法。Unicycive 的另一款药物 UNI-494 是一种新的化学实体，在晚期临床前开发中已获得物质成分专利保护，用于治疗急性肾损伤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127032639971a8b3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127032639971a8b3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","UNCY","LENZ","BK4539"],"gpt_icon":0},{"id":"2483809095","title":"Unicycive Therapeutics, Inc.盘中异动 股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483809095","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483809095?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:31","pubTimestamp":1731594685,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时31分，Unicycive Therapeutics, Inc.股票出现波动，股价快速下跌5.21%。Unicycive Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。其相关个股中，Elevai Labs, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Elevai Labs, Inc.、Calidi Biotherapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1403.84%、19.59%、11.31%，振幅较大的相关个股有Pulmatrix, Inc.、Cargo Therapeutics, Inc.、Heron Therapeutics, Inc.，振幅分别为9.83%、8.67%、8.60%。Unicycive Therapeutics, Inc.公司简介：Unicycive Therapeutics Inc是一家生物技术公司，致力于开发针对某些疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422312598e42a05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422312598e42a05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["UNCY","BK4139","LENZ","BK4539"],"gpt_icon":0},{"id":"2476498120","title":"Unicycive Therapeutics, Inc.盘中异动 早盘大幅拉升5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476498120","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476498120?lang=zh_cn&edition=full","pubTime":"2024-10-17 21:41","pubTimestamp":1729172479,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日21时41分，Unicycive Therapeutics, Inc.股票出现波动，股价急速上涨5.66%。Unicycive Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Psyence Biomedical Ltd C/Wts 25/01/2029、Molecular Templates, Inc.涨幅较大，Notable Labs, Ltd.、Molecular Templates, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为317.36%、225.32%、146.29%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Molecular Templates, Inc.、Tevogen Bio Holdings Inc.，振幅分别为56.36%、37.28%、28.85%。Unicycive Therapeutics, Inc.公司简介：Unicycive Therapeutics Inc是一家生物技术公司，致力于开发针对某些疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017214120ab6ad87a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017214120ab6ad87a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","UNCY","LENZ","BK4139"],"gpt_icon":0},{"id":"2460040540","title":"Unicycive Therapeutics, Inc.盘中异动 早盘急速下挫5.28%报0.355美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460040540","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460040540?lang=zh_cn&edition=full","pubTime":"2024-08-20 21:31","pubTimestamp":1724160675,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日21时31分，Unicycive Therapeutics, Inc.股票出现异动，股价快速下跌5.28%。Unicycive Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Unicycive Therapeutics, Inc.公司简介：Unicycive Therapeutics Inc是一家生物技术公司，致力于开发针对某些疾病的治疗方法。Unicycive 的另一款药物 UNI-494 是一种新的化学实体，在晚期临床前开发中已获得物质成分专利保护，用于治疗急性肾损伤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820213121ab5ea2ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820213121ab5ea2ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","UNCY","LENZ"],"gpt_icon":0},{"id":"2460028717","title":"Unicycive Therapeutics, Inc.2024财年第二财季实现净利润3.93百万美元，同比增加202.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460028717","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460028717?lang=zh_cn&edition=full","pubTime":"2024-08-19 00:01","pubTimestamp":1723996882,"startTime":"0","endTime":"0","summary":"8月19日，Unicycive Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为3.93百万美元，同比增加202.34%；其中营业收入为0.00美元，每股基本收益为0.08美元。机构评级：截至2024年8月19日，当前有7家机构对Unicycive Therapeutics, Inc.目标价做出预测，其中目标均价为6.07美元，其中最低目标价为2.50美元，最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408190001319f363b75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408190001319f363b75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["UNCY","LENZ"],"gpt_icon":0},{"id":"2456906435","title":"Unicycive Therapeutics, Inc.盘中异动 早盘急速下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456906435","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456906435?lang=zh_cn&edition=full","pubTime":"2024-08-01 22:01","pubTimestamp":1722520912,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日22时01分，Unicycive Therapeutics, Inc.股票出现异动，股价急速跳水5.06%。Unicycive Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Immuneering Corporation、Biomea Fusion, Inc.、Windtree Therapeutics, Inc.涨幅较大，Windtree Therapeutics, Inc.、Immuneering Corporation、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为192.17%、157.27%、71.20%，振幅较大的相关个股有Windtree Therapeutics, Inc.、Immuneering Corporation、Biomea Fusion, Inc.，振幅分别为40.35%、29.20%、27.92%。Unicycive Therapeutics, Inc.公司简介：Unicycive Therapeutics Inc是一家生物技术公司，致力于开发针对某些疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801220153941fd039&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801220153941fd039&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4139","UNCY"],"gpt_icon":0},{"id":"2452476415","title":"Unicycive Therapeutics, Inc.盘中异动 股价大涨8.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452476415","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452476415?lang=zh_cn&edition=full","pubTime":"2024-07-19 21:31","pubTimestamp":1721395881,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日21时31分，Unicycive Therapeutics, Inc.股票出现异动，股价大幅上涨8.32%。Unicycive Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。其相关个股中，60 Degrees Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，60 Degrees Pharmaceuticals, Inc.、Silo Pharma, Inc.、Altamira Therapeutics Ltd.较为活跃，换手率分别为555.15%、212.96%、105.67%，振幅较大的相关个股有60 Degrees Pharmaceuticals, Inc.、Altamira Therapeutics Ltd.、Solid Biosciences Inc.，振幅分别为16.26%、8.96%、7.05%。Unicycive Therapeutics, Inc.公司简介：Unicycive Therapeutics Inc是一家生物技术公司，致力于开发针对某些疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071921312195dcf9d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071921312195dcf9d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["UNCY","LENZ","BK4539","BK4139"],"gpt_icon":0},{"id":"2452132084","title":"美国专利商标局授予Unicycive Therapeutics公司治疗急性肾损伤的Uni-494专利","url":"https://stock-news.laohu8.com/highlight/detail?id=2452132084","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452132084?lang=zh_cn&edition=full","pubTime":"2024-07-17 19:03","pubTimestamp":1721214183,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","BK4539","UNCY","LENZ"],"gpt_icon":0},{"id":"2450289835","title":"Unicycive Therapeutics Inc-交换到Olc后每日药丸量中位数减少一半","url":"https://stock-news.laohu8.com/highlight/detail?id=2450289835","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450289835?lang=zh_cn&edition=full","pubTime":"2024-07-10 19:03","pubTimestamp":1720609418,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4539","BK4139","UNCY","LENZ"],"gpt_icon":0},{"id":"2450860794","title":"Unicycive Therapeutics宣布Oxylanthanum Carbonate (Olc)关键性临床试验的初步患者满意度研究结果为积极。","url":"https://stock-news.laohu8.com/highlight/detail?id=2450860794","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450860794?lang=zh_cn&edition=full","pubTime":"2024-07-10 19:03","pubTimestamp":1720609380,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LENZ","BK4539","BK1141","03347","BK1583","BK4139","UNCY","BK1576"],"gpt_icon":0},{"id":"2449426287","title":"BUZZ-印度希尔帕医疗保险公司因药物试验取得积极成果而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2449426287","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449426287?lang=zh_cn&edition=full","pubTime":"2024-07-05 12:45","pubTimestamp":1720154739,"startTime":"0","endTime":"0","summary":"    7月5日 - ** Shilpa Medicare   股价上涨多达15.4%；最后上涨约11%，报642卢比，为2021年7月以来最高价 ** 该制药公司称，  Unicycive Therapeutics    报告了 ShME 的 Oxylanthanum Carbonate 药物试验的积极结果。** 用于治疗慢性肾病患者高磷血症的药物** UNCY 将在 2025 年 6 月 30 日之前发出 OLC 药片供应采购订单** 该股迎来 4 月中旬以来最繁忙的交易时段，成交量超过 30 天平均值的 4.4 倍 ** 本交易日的涨幅使该股每周上涨约 12.4%，SHME 将迎来自 2 月下旬以来的最大单周涨幅","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","BK4139","UNCY","BK4539"],"gpt_icon":0},{"id":"2448080199","title":"Unicycive Therapeutics：根据修正案公司将下达买单购买Olc药片Shilpa同意在2025年6月30日前交付该订单。","url":"https://stock-news.laohu8.com/highlight/detail?id=2448080199","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448080199?lang=zh_cn&edition=full","pubTime":"2024-07-03 04:18","pubTimestamp":1719951493,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LENZ","BK4139","BK4539","UNCY"],"gpt_icon":0},{"id":"2446582623","title":"HC Wainwright &amp; Co.：重申Unicycive Therapeutics(UNCY.US)评级，由买入调整至买入评级, 目标价由4.","url":"https://stock-news.laohu8.com/highlight/detail?id=2446582623","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446582623?lang=zh_cn&edition=full","pubTime":"2024-06-26 00:11","pubTimestamp":1719331904,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["UNCY","BK4139","BK4539","LENZ"],"gpt_icon":0},{"id":"2446084601","title":"Unicycive Therapeutics, Inc.盘中异动 股价大跌9.98%报0.615美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446084601","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446084601?lang=zh_cn&edition=full","pubTime":"2024-06-25 21:31","pubTimestamp":1719322294,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日21时31分，Unicycive Therapeutics, Inc.股票出现异动，股价快速跳水9.98%。Unicycive Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。其相关个股中，Glycomimetics, Inc.、Senti Biosciences, Inc.、Anew Medical, Inc.涨幅较大，Effector Therapeutics, Inc.、Glycomimetics, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为84.96%、78.39%、56.72%，振幅较大的相关个股有Glycomimetics, Inc.、Lipella Pharmaceuticals Inc.、Geovax Labs, Inc.，振幅分别为12.94%、12.48%、9.92%。Unicycive Therapeutics, Inc.公司简介：Unicycive Therapeutics Inc是一家生物技术公司，致力于开发针对某些疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406252131359f640e1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406252131359f640e1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["UNCY","BK4139","LENZ","BK4539"],"gpt_icon":0},{"id":"2446110208","title":"Unicycive Therapeutics公司：成功确立Olc的良好耐受性和安全性","url":"https://stock-news.laohu8.com/highlight/detail?id=2446110208","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446110208?lang=zh_cn&edition=full","pubTime":"2024-06-25 19:30","pubTimestamp":1719315053,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","UNCY","LENZ","BK4539"],"gpt_icon":0},{"id":"2446811029","title":"Unicycive Therapeutics公司：预计于2024年第三季度提交新药申请（NDA）","url":"https://stock-news.laohu8.com/highlight/detail?id=2446811029","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446811029?lang=zh_cn&edition=full","pubTime":"2024-06-25 19:30","pubTimestamp":1719315050,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","LENZ","UNCY","BK4539"],"gpt_icon":0},{"id":"2446811041","title":"Unicycive Therapeutics在氧迦兰碳酸盐（Olc）关键临床试验中达成研究目标。","url":"https://stock-news.laohu8.com/highlight/detail?id=2446811041","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446811041?lang=zh_cn&edition=full","pubTime":"2024-06-25 19:30","pubTimestamp":1719315000,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LENZ","03347","BK4139","BK1583","BK4539","BK1141","BK1576","UNCY"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.unicycive.com","stockEarnings":[{"period":"1week","weight":-0.0427},{"period":"1month","weight":0.3428},{"period":"3month","weight":0.487},{"period":"6month","weight":0.0765},{"period":"1year","weight":0.2},{"period":"ytd","weight":-0.2117}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Unicycive Therapeutics, Inc.于2016年8月18日在特拉华州注册成立。该公司一直处于休眠状态，直到2017年7月开始评估许可使用的多种药物。他们是一家生物技术公司，致力于为未满足的医疗条件开发治疗方法。当前，他们的两个计划针对有可能提供医疗收益的肾脏疾病。随着公司的发展和团队的建立，他们打算专注于确定肾脏疾病内外的医疗状况。他们目前的开发计划着重于两种新型疗法的开发：UNI 218或Renazorb（用于治疗慢性肾脏病患者的高磷酸盐血症）和UNI 494（用于治疗急性肾脏损伤）。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":-0.066071},{"month":2,"riseRate":0.666667,"avgChangeRate":0.127697},{"month":3,"riseRate":0.333333,"avgChangeRate":0.996651},{"month":4,"riseRate":0,"avgChangeRate":-0.298132},{"month":5,"riseRate":0.666667,"avgChangeRate":-0.055066},{"month":6,"riseRate":0,"avgChangeRate":-0.179728},{"month":7,"riseRate":0,"avgChangeRate":-0.107364},{"month":8,"riseRate":0.25,"avgChangeRate":-0.144614},{"month":9,"riseRate":0.5,"avgChangeRate":0.038379},{"month":10,"riseRate":0.75,"avgChangeRate":0.041357},{"month":11,"riseRate":0.5,"avgChangeRate":-0.014685},{"month":12,"riseRate":0.25,"avgChangeRate":0.110207}],"exchange":"NASDAQ","name":"Unicycive Therapeutics, Inc.","nameEN":"Unicycive Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Unicycive Therapeutics, Inc.(UNCY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Unicycive Therapeutics, Inc.(UNCY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Unicycive Therapeutics, Inc.,UNCY,Unicycive Therapeutics, Inc.股票,Unicycive Therapeutics, Inc.股票老虎,Unicycive Therapeutics, Inc.股票老虎国际,Unicycive Therapeutics, Inc.行情,Unicycive Therapeutics, Inc.股票行情,Unicycive Therapeutics, Inc.股价,Unicycive Therapeutics, Inc.股市,Unicycive Therapeutics, Inc.股票价格,Unicycive Therapeutics, Inc.股票交易,Unicycive Therapeutics, Inc.股票购买,Unicycive Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Unicycive Therapeutics, Inc.(UNCY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Unicycive Therapeutics, Inc.(UNCY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}